ORTHOPEDIATRICS CORP 8-K

What Happened OrthoPediatrics Corp. filed a Form 8‑K on January 12, 2026 (Item 7.01) to disclose that its executive officers will make presentations to investors and analysts and intend to use the material filed as Exhibit 99.1. The filing includes an attached investor presentation titled "Orthopediatrics Corp. Investor Presentation dated January 2026." The report was signed by Daniel J. Gerritzen, General Counsel and Secretary.

Key Details

• Filing date: January 12, 2026; reported under Item 7.01 (Regulation FD Disclosure).
• Exhibit included: Exhibit 99.1 — "Orthopediatrics Corp. Investor Presentation dated January 2026."
• Administrative exhibit: Exhibit 104 (Cover Page Interactive Data File) was also included.
• Signed by: Daniel J. Gerritzen, General Counsel and Secretary.

Why It Matters This is a Regulation FD disclosure providing broader access to materials company executives will use in investor and analyst presentations. It is an informational filing rather than a report of earnings, executive changes, or transactions; investors should review Exhibit 99.1 for any operational or financial updates the company may present.